|
| Clinical trials | Results | References |
|
| Exercise performance | Improves strength performance and endurance and accelerates postexercise recovery | [278] |
| Cognitive function | Cognitive improvement in overweight men; improves visual learning | [279] |
| Skin conditions | Induce improvement in patients with hyperpigmentation and dark spots | [280] |
| Patients with melasma showed significant improvement after treatment | [281, 282] |
| Lead to increased UV damage protection | [283] |
| Have antiwrinkle activity, increasing the expression of type I collagen mRNA | [284] |
| Insulin resistance and diabetes | Induce reduction in blood glucose levels | [285, 286] |
| Weight and body composition | No significant effect on body weight, body mass index, waist circumference, or body fat percentage | [287] |
| Cardiovascular disease risk factors | Decrease carotid artery intima-media thickness; decrease in mean peak systolic velocity and end-diastolic velocity of carotid arteries | [288] |
| Reduction in stress-induced ischemia | [289] |
| Significant reductions in systolic and diastolic blood pressure | [290, 291] |
| No effect on plasma concentrations of cholesterol, LDL-C, HDL-C, or triglycerides | [292, 293] |
| Osteoarthritis | Significant decrease in WOMAC stiffness and physical function scores | [294] |
| Fatigue, insomnia | Improvement in fatigue and insomnia questionnaire scores | [295] |
| Prostate cancer | Ellagic acid effects as adjuvant therapy for chemotherapeutic treatment: less risk of developing neutropenia than patients receiving chemotherapy alone; PSA reduction; reduction gastrointestinal side effects | [296] |
| Human fertility | Increase in total number of motile spermatozoa | [297] |
|
